
Guardion Health Sciences GHSI
Quarterly report 2024-Q2
added 08-13-2024
Guardion Health Sciences Shares 2011-2026 | GHSI
Annual Shares Guardion Health Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.12 M | 474 K | 14.3 M | 6.08 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.3 M | 474 K | 5.48 M |
Quarterly Shares Guardion Health Sciences
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.28 M | 1.28 M | 1.28 M | 1.27 M | 1.27 M | 1.27 M | 1.27 M | 1.23 M | 1.23 M | 783 K | 24.4 M | 24.4 M | 24.4 M | 21.4 M | 15.2 M | 14.7 M | 14.4 M | 13.1 M | 12.5 M | 36 M | 22.5 M | 20.7 M | 20.6 M | 20.2 M | 20.2 M | 20.2 M | 20.1 M | 25.8 M | 25.5 M | 24.8 M | 24.7 M | 21.4 M | 21.3 M | 21 M | 21.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 36 M | 783 K | 15.5 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
187 M | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B | ||
|
Autolus Therapeutics plc
AUTL
|
266 M | $ 1.39 | -0.36 % | $ 370 M | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | ||
|
Alterity Therapeutics Limited
ATHE
|
2.41 B | $ 3.72 | 3.24 % | $ 8.95 B | ||
|
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | ||
|
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | ||
|
Aytu BioScience
AYTU
|
6.28 M | $ 2.58 | -3.2 % | $ 16.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
2.45 M | - | -45.71 % | $ 1.2 M | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | ||
|
BioNTech SE
BNTX
|
244 M | $ 89.2 | -2.28 % | $ 27.2 B | ||
|
Coherus BioSciences
CHRS
|
117 M | $ 1.64 | -2.1 % | $ 192 M | ||
|
Akari Therapeutics, Plc
AKTX
|
67.3 B | $ 3.4 | -3.95 % | $ 229 B | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
86.8 M | - | - | $ 28.6 M | ||
|
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
131 M | $ 321.48 | -2.68 % | $ 42.1 B | ||
|
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
25.4 M | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
15.3 M | - | 4.14 % | $ 49.1 M | ||
|
Burford Capital Limited
BUR
|
219 M | $ 4.47 | 0.11 % | $ 729 M | ||
|
Atreca
BCEL
|
38.6 M | - | -11.76 % | $ 5.79 M | ||
|
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | ||
|
argenx SE
ARGX
|
51.1 M | $ 757.61 | 1.25 % | $ 25 B | ||
|
Завод ДИОД
DIOD
|
91.5 M | - | - | - | ||
|
Фармсинтез
LIFE
|
301 M | - | - | - | ||
|
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | ||
|
Aptorum Group Limited
APM
|
5.45 M | $ 0.88 | -0.58 % | $ 4.8 M | ||
|
Applied Therapeutics
APLT
|
84.2 M | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | ||
|
Teligent, Inc.
TLGT
|
5.59 M | - | -13.85 % | $ 16.1 M | ||
|
Cerus Corporation
CERS
|
191 M | $ 1.88 | 1.35 % | $ 358 M | ||
|
AbbVie
ABBV
|
1.77 B | $ 205.21 | -0.69 % | $ 363 B | ||
|
Aquestive Therapeutics
AQST
|
107 M | $ 4.09 | - | $ 437 M | ||
|
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | ||
|
Viela Bio, Inc.
VIE
|
12.3 M | - | - | $ 2.91 B | ||
|
AbCellera Biologics
ABCL
|
299 M | $ 3.34 | -1.62 % | $ 998 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
27.4 M | $ 8.41 | 2.37 % | $ 230 M |